CAROLINA DE VARONA: Open Payments
NPI 1679965586 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 10 payments from 8 companies in 2025. Trend: 2023 $880 · 2024 $147 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 1 | $161 |
| Aimmune Therapeutics, Inc. | 2 | $59 |
| ABBVIE INC. | 2 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: IBSRELA, ZENPEP, RINVOQ, XIFAXAN, VOQUEZNA, MYRISK, TREMFYA.
Industry payments across FL — which companies pay providers there.
